bioRxivMicrobiologyPreprint
mRNA cap-binding protein eIF4E1 is a novel regulator of Toxoplasma gondii latency
M. J. Holmes, M. S. Bastos, V. Dey, V. Severo, R. C. Wek, W. J. Sullivan
Abstract
The protozoan parasite Toxoplasma gondii causes serious opportunistic disease due to its ability to persist in patients as latent tissue cysts. The molecular mechanisms coordinating conversion between proliferative parasites (tachyzoites) and dormant cysts (bradyzoites) are not fully understood. We previously showed that phosphorylation of eIF2 accompanies bradyzoite formation, suggesting that this clinically relevant process involves regulation of mRNA translation. In this study, we investigated the composition and role of eIF4F multi-subunit complexes in translational control. Using CLIPseq, we find that the cap-binding subunit, eIF4E1, localizes to the 5-end of all tachyzoite mRNAs, many of which show evidence of stemming from heterogenous transcriptional start sites. We further show that eIF4E1 operates as the predominant cap-binding protein in two distinct eIF4F complexes. Using genetic and pharmacological approaches, we found that eIF4E1 deficiency triggers efficient spontaneous formation of bradyzoites without stress induction. Consistent with this result, we also show that stress-induced bradyzoites exhibit reduced eIF4E1 expression. Overall, our findings establish a novel role for eIF4F in translational control required for parasite latency and microbial persistence. SignificanceToxoplasma gondii is an opportunistic pathogen of importance to global human and animal health. There are currently no chemotherapies targeting the encysted form of the parasite. Consequently, a better understanding of the mechanisms controlling encystation are required. Here we show that the mRNA cap-binding protein, eIF4E1, is involved in regulating the encystation process. Encysted parasites reduce eIF4E1 levels and depletion of eIF4E1 decreases the translation of ribosome-associated machinery and drives Toxoplasma encystation. Together, these data reveal a new layer of mRNA translational control that regulates parasite encystation and latency.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cap-independent translation directs stress-induced differentiation of the protozoan parasite Toxoplasma gondii
Vishakha Dey, Michael J. Holmes, … William J. Sullivan·Journal of Biological ChemistryPeer-reviewed·Nov 13, 2024
- Translation initiation factor eIF1.2 promotes Toxoplasma stage conversion by regulating levels of key differentiation factors
F. Wang, M. J. Holmes, … V. B. Carruthers·bioRxiv·Nov 3, 2023
- Mechanisms of translation repression by the EIF4E1-4EIP cap-binding complex of Trypanosoma brucei: potential roles of the NOT complex and a terminal uridylyl transferase
Franziska Falk, Kevin Kamanyi Marucha, CHRISTINE E. CLAYTON·PLoS ONEPeer-reviewed·Nov 22, 2021
- The suppressive cap-binding-complex factor 4EIP is required for normal differentiation
Monica Cristina Terrão, Kevin Kamanyi Marucha, … CHRISTINE E. CLAYTON·Nucleic Acids ResearchPeer-reviewed·Aug 1, 2018
- Toxoplasma gondii bradyzoites induce transcriptional changes to host cells and prevent IFNγ-mediated cell death
C. J. Tonkin, S. Seizova, … K. Rogers·bioRxiv·Jun 13, 2019
- In vitro characterization of protein effector export in the bradyzoite stage of Toxoplasma gondii
J. A. Mayoral, P. Shamamian, L. M. Weiss·mBioPeer-reviewed·Apr 28, 2020